Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).
Clinical trial NCT06550128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06550128
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2025-05-26
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.